N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine

C17H28N2 — CID 43752241

IUPACN-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine
SMILESC1CC2C3CC(NC4CCN5CCCC45)C(C3)C2C1
InChIInChI=1S/C17H28N2/c1-3-12-11-9-14(13(12)4-1)16(10-11)18-15-6-8-19-7-2-5-17(15)19/h11-18H,1-10H2
InChIKeyUJXZOXFXXPHMJK-UHFFFAOYSA-N
MW260.42 g/mol
LogP2.64
Rot. Bonds2

About N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine

N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine (PubChem CID 43752241) has the molecular formula C17H28N2 and a molecular weight of 260.42 g/mol. Its IUPAC name is N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine.

Molecular Properties

Compound NameN-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine
PubChem CID43752241
Molecular FormulaC17H28N2
Molecular Weight260.42 g/mol
Exact Mass260.23
IUPAC NameN-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine
SMILESC1CC2C3CC(NC4CCN5CCCC45)C(C3)C2C1
InChIInChI=1S/C17H28N2/c1-3-12-11-9-14(13(12)4-1)16(10-11)18-15-6-8-19-7-2-5-17(15)19/h11-18H,1-10H2
InChIKeyUJXZOXFXXPHMJK-UHFFFAOYSA-N
XLogP2.64
TPSA15.27 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds2
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500260.42
LogP ≤ 52.64
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Analyze N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-cyclopropyl-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine
CID 82852848
1,3-dimethyl-N-(8-tricyclo[5.2.1.02,6]decanyl)piperidin-4-amine
CID 115714383
N-(2-methylcyclohexyl)tricyclo[5.2.1.02,6]decan-8-amine
CID 43392260
N-(2-methoxycyclohexyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine
CID 43792646
N-(2-pyrrolidin-2-ylcyclohexyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine
CID 79536664
trans-(1S,2S)-2-(1,2,3,5,6,7,8,8a-octahydroindolizin-1-ylamino)cyclopentan-1-ol
CID 102733298
N-(2-pyrrolidin-2-ylcyclopentyl)-1,2,3,5,6,7,8,8a-octahydroindolizin-1-amine
CID 79536385
2-methyl-N-(8-tricyclo[5.2.1.02,6]decanyl)oxolan-3-amine
CID 115337056
N-cyclooctyl-1,2,3,5,6,7,8,8a-octahydroindolizin-1-amine
CID 43694307
4-(2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-ylamino)cyclohexan-1-ol
CID 82853106
2-(1,2,3,5,6,7,8,8a-octahydroindolizin-1-ylamino)cyclopentane-1-carbonitrile
CID 62741172
N-(3-methoxycyclohexyl)tricyclo[5.2.1.02,6]decan-8-amine
CID 103904074

Frequently Asked Questions

What is the IUPAC name of N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine?
The IUPAC name of N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine (CID 43752241) is N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine.
What is the SMILES notation for N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine?
The canonical SMILES for N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine is C1CC2C3CC(NC4CCN5CCCC45)C(C3)C2C1.
What is the InChIKey of N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine?
The InChIKey is UJXZOXFXXPHMJK-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H28N2/c1-3-12-11-9-14(13(12)4-1)16(10-11)18-15-6-8-19-7-2-5-17(15)19/h11-18H,1-10H2.
What are the key properties of N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine?
N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine has a molecular weight of 260.42 g/mol, XLogP of 2.64, 2 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for N-(8-tricyclo[5.2.1.02,6]decanyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-amine is sourced from PubChem (CID 43752241), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).